id | C00001071 |
---|---|
Name | Myricetin |
CAS RN | 529-44-2 |
Standard InChI | InChI=1S/C15H10O8/c16-6-3-7(17)11-10(4-6)23-15(14(22)13(11)21)5-1-8(18)12(20)9(19)2-5/h1-4,16-20,22H |
Standard InChI (Main Layer) | InChI=1S/C15H10O8/c16-6-3-7(17)11-10(4-6)23-15(14(22)13(11)21)5-1-8(18)12(20)9(19)2-5/h1-4,16-20,22H |
Phytochemical cluster | No. 15 |
---|---|
KCF-S cluster | No. 3 |
By standard InChI | CHEMBL164 |
---|---|
By standard InChI Main Layer | CHEMBL164 |
By LinkDB | C10107 |
---|
By CAS RN | C040015 |
---|
class name | count |
---|---|
rosids | 66 |
asterids | 3 |
eudicotyledons | 2 |
Spermatophyta | 1 |
Magnoliophyta | 1 |
Liliopsida | 1 |
family name | count |
---|---|
Fabaceae | 49 |
Myrtaceae | 5 |
Anacardiaceae | 3 |
Myricaceae | 2 |
Elaeagnaceae | 1 |
Nymphaeaceae | 1 |
Pinaceae | 1 |
Xanthoceraceae | 1 |
Phyllanthaceae | 1 |
Cunoniaceae | 1 |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL164 |
CHEMBL1614110
(1)
CHEMBL1741321
(2)
|
1 / 0 |
P42345 | Serine/threonine-protein kinase mTOR | Enzyme | CHEMBL164 |
CHEMBL1613805
(1)
CHEMBL1614293
(1)
|
0 / 0 |
P33527 | Multidrug resistance-associated protein 1 | drugs | CHEMBL164 |
CHEMBL1062294
(1)
CHEMBL1062295
(1)
CHEMBL2077005 (1) |
0 / 0 |
P31941 | DNA dC->dU-editing enzyme APOBEC-3A | Enzyme | CHEMBL164 |
CHEMBL1737903
(1)
|
0 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | CHEMBL164 |
CHEMBL1738312
(1)
|
0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | CHEMBL164 |
CHEMBL1794367
(1)
CHEMBL2114784
(2)
|
1 / 1 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | CHEMBL164 |
CHEMBL1794499
(2)
|
2 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | CHEMBL164 |
CHEMBL1738565
(1)
|
0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | CHEMBL164 |
CHEMBL1014033
(1)
CHEMBL1014036
(1)
|
0 / 3 |
P06746 | DNA polymerase beta | Enzyme | CHEMBL164 |
CHEMBL1614079
(1)
|
0 / 0 |
P04062 | Glucosylceramidase | Enzyme | CHEMBL164 |
CHEMBL1613818
(2)
|
6 / 4 |
P42336 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Enzyme | CHEMBL164 |
CHEMBL1942593
(1)
CHEMBL1942598
(1)
|
9 / 1 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | CHEMBL164 |
CHEMBL1738600
(1)
CHEMBL1794585
(1)
|
0 / 0 |
P28907 | ADP-ribosyl cyclase 1 | Enzyme | CHEMBL164 |
CHEMBL1799589
(1)
|
0 / 1 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | CHEMBL164 |
CHEMBL1614331
(1)
CHEMBL1613927
(1)
|
0 / 0 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | CHEMBL164 |
CHEMBL1023248
(1)
|
1 / 1 |
P11309 | Serine/threonine-protein kinase pim-1 | Pim | CHEMBL164 |
CHEMBL862675
(1)
CHEMBL862676
(1)
CHEMBL926333 (1) |
0 / 0 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | CHEMBL164 |
CHEMBL1780345
(1)
|
0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL164 |
CHEMBL1614027
(3)
CHEMBL1741325
(2)
|
0 / 1 |
P54132 | Bloom syndrome protein | Enzyme | CHEMBL164 |
CHEMBL1614522
(1)
CHEMBL1614067
(4)
|
1 / 2 |
Q9HC97 | G-protein coupled receptor 35 | Kynurenic acid receptor | CHEMBL164 |
CHEMBL2039370
(1)
CHEMBL2039371
(1)
CHEMBL2039372 (1) CHEMBL2039375 (1) CHEMBL2039376 (1) CHEMBL2039377 (1) CHEMBL2039379 (1) |
0 / 0 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | CHEMBL164 |
CHEMBL1614166
(1)
|
1 / 0 |
P11387 | DNA topoisomerase 1 | Isomerase | CHEMBL164 |
CHEMBL987597
(1)
|
0 / 0 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | CHEMBL164 |
CHEMBL1014686
(1)
CHEMBL1014697
(1)
CHEMBL1014698 (1) CHEMBL1014699 (1) CHEMBL1014700 (1) CHEMBL987598 (1) |
0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | CHEMBL164 |
CHEMBL1794311
(2)
|
2 / 3 |
Q15746 | Myosin light chain kinase, smooth muscle | Mlck | CHEMBL164 |
CHEMBL971891
(1)
|
1 / 1 |
Q9Y3R4 | Sialidase-2 | Enzyme | CHEMBL164 |
CHEMBL1100507
(1)
|
0 / 0 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | CHEMBL164 |
CHEMBL1613800
(3)
|
0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL164 |
CHEMBL1614458
(3)
|
0 / 0 |
P36888 | Receptor-type tyrosine-protein kinase FLT3 | Pdgfr | CHEMBL164 |
CHEMBL2342404
(1)
|
1 / 1 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | CHEMBL164 |
CHEMBL1614456
(1)
CHEMBL1613803
(1)
|
0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | CHEMBL164 |
CHEMBL1613922
(1)
CHEMBL1794486
(5)
|
0 / 0 |
P15121 | Aldose reductase | Enzyme | CHEMBL164 |
CHEMBL936594
(1)
|
0 / 0 |
Q14790 | Caspase-8 | C14 | CHEMBL164 |
CHEMBL2014551
(1)
|
2 / 1 |
Q9Y253 | DNA polymerase eta | Enzyme | CHEMBL164 |
CHEMBL1794569
(2)
|
1 / 1 |
P09923 | Intestinal-type alkaline phosphatase | Enzyme | CHEMBL164 |
CHEMBL1738315
(1)
|
0 / 0 |
P05186 | Alkaline phosphatase, tissue-nonspecific isozyme | Enzyme | CHEMBL164 |
CHEMBL1738602
(1)
|
3 / 1 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | CHEMBL164 |
CHEMBL1614280
(1)
CHEMBL1794529
(1)
|
0 / 0 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | CHEMBL164 |
CHEMBL1614257
(4)
CHEMBL1614410
(1)
CHEMBL1614531 (4) |
1 / 3 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | CHEMBL164 |
CHEMBL1738610
(1)
CHEMBL1794401
(1)
|
0 / 0 |
Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | CHEMBL164 |
CHEMBL1738408
(1)
|
0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | CHEMBL164 |
CHEMBL1794467
(2)
|
0 / 0 |
P06213 | Insulin receptor | TK tyrosine-protein kinase INSR subfamily | CHEMBL164 |
CHEMBL941409
(1)
|
5 / 4 |
P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | CHEMBL164 |
CHEMBL987970
(1)
|
2 / 2 |
Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | CHEMBL164 |
CHEMBL1780346
(1)
|
4 / 4 |
P06276 | Cholinesterase | Hydrolase | CHEMBL164 |
CHEMBL1045780
(1)
CHEMBL1045783
(1)
|
0 / 0 |
P04745 | Alpha-amylase 1 | Enzyme | CHEMBL164 |
CHEMBL964479
(2)
|
0 / 0 |
P18054 | Arachidonate 12-lipoxygenase, 12S-type | Enzyme | CHEMBL164 |
CHEMBL1614252
(1)
|
2 / 0 |
P10696 | Alkaline phosphatase, placental-like | Enzyme | CHEMBL164 |
CHEMBL1738514
(1)
|
0 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL164 |
CHEMBL1741322
(2)
|
0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | CHEMBL164 |
CHEMBL1613910
(3)
CHEMBL1614227
(3)
|
3 / 3 |
Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | CHEMBL164 |
CHEMBL1062296
(1)
|
1 / 1 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | CHEMBL164 |
CHEMBL1614038
(3)
|
2 / 2 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | CHEMBL164 |
CHEMBL1614171
(1)
|
5 / 2 |
P22303 | Acetylcholinesterase | Hydrolase | CHEMBL164 |
CHEMBL1045781
(1)
|
1 / 0 |
Q02880 | DNA topoisomerase 2-beta | Isomerase | CHEMBL164 |
CHEMBL687375
(1)
|
0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | CHEMBL164 |
CHEMBL1614240
(3)
|
0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL164 |
CHEMBL1613777
(3)
CHEMBL1741323
(2)
|
1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL164 |
CHEMBL1614108
(3)
CHEMBL1613886
(3)
CHEMBL1741324 (2) |
0 / 1 |
Q9UNA4 | DNA polymerase iota | Enzyme | CHEMBL164 |
CHEMBL1794483
(5)
|
0 / 0 |
Q15046 | Lysine--tRNA ligase | Enzyme | CHEMBL164 |
CHEMBL2173401
(1)
CHEMBL2173408
(1)
|
2 / 1 |
O75164 | Lysine-specific demethylase 4A | Enzyme | CHEMBL164 |
CHEMBL1737991
(1)
|
0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | CHEMBL164 |
CHEMBL1614283
(1)
CHEMBL1614466
(1)
CHEMBL1614211 (4) |
0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL164 |
CHEMBL1614250
(2)
CHEMBL1614421
(2)
CHEMBL1614502 (2) |
4 / 3 |
Q99549 | M-phase phosphoprotein 8 | Unclassified protein | CHEMBL164 |
CHEMBL1738402
(2)
|
0 / 0 |
Q04760 | Lactoylglutathione lyase | Enzyme | CHEMBL164 |
CHEMBL967534
(1)
CHEMBL1913551
(1)
|
0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL164 |
CHEMBL1794536
(8)
|
0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | CHEMBL164 |
CHEMBL1613914
(3)
CHEMBL1798570
(1)
|
0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | CHEMBL164 |
CHEMBL1614330
(1)
CHEMBL1613829
(4)
|
0 / 0 |
P40225 | Thrombopoietin | Unclassified protein | CHEMBL164 |
CHEMBL1614086
(1)
CHEMBL1614034
(1)
|
1 / 1 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | CHEMBL164 |
CHEMBL1738442
(4)
|
0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | CHEMBL164 |
CHEMBL1614364
(4)
|
1 / 1 |
O00255 | Menin | Unclassified protein | CHEMBL164 |
CHEMBL1614257
(4)
CHEMBL1614531
(4)
|
2 / 5 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | CHEMBL164 |
CHEMBL1613933
(2)
|
0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | CHEMBL164 |
CHEMBL1613933
(2)
|
1 / 6 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | CHEMBL164 |
CHEMBL2114738
(1)
|
0 / 0 |
Q14191 | Werner syndrome ATP-dependent helicase | Enzyme | CHEMBL164 |
CHEMBL2114796
(1)
|
2 / 1 |
Q9HCT0 | Fibroblast growth factor 22 | Unclassified protein | CHEMBL164 |
CHEMBL2354256
(1)
|
0 / 0 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
C040015 | 4363 |
ABCC1
ABC29 ABCC GS-X MRP MRP1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | myricetin inhibits the reaction [ABCC1 protein affects the export of and results in decreased susceptibility to Vincristine] |
affects export
/ decreases reaction / decreases response to substance |
protein |
15896345
|
C040015 | 4363 |
ABCC1
ABC29 ABCC GS-X MRP MRP1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | myricetin inhibits the reaction [ABCC1 protein affects the export of Vincristine] |
affects export
/ decreases reaction |
protein |
15896345
|
C040015 | 4363 |
ABCC1
ABC29 ABCC GS-X MRP MRP1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | myricetin inhibits the reaction [ABCC1 protein results in decreased susceptibility to Vincristine] |
decreases reaction
/ decreases response to substance |
protein |
15896345
|
C040015 | 4363 |
ABCC1
ABC29 ABCC GS-X MRP MRP1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | myricetin results in decreased activity of ABCC1 protein |
decreases activity
|
protein |
15670588
|
C040015 | 1244 |
ABCC2
ABC30 CMOAT DJS MRP2 cMRP |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | myricetin inhibits the reaction [ABCC2 protein affects the export of and results in decreased susceptibility to Vincristine] |
affects export
/ decreases reaction / decreases response to substance |
protein |
15896345
|
C040015 | 1244 |
ABCC2
ABC30 CMOAT DJS MRP2 cMRP |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | myricetin inhibits the reaction [ABCC2 protein affects the export of Vincristine] |
affects export
/ decreases reaction |
protein |
15896345
|
C040015 | 1244 |
ABCC2
ABC30 CMOAT DJS MRP2 cMRP |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | myricetin inhibits the reaction [ABCC2 protein results in decreased susceptibility to Vincristine] |
decreases reaction
/ decreases response to substance |
protein |
15896345
|
C040015 | 1244 |
ABCC2
ABC30 CMOAT DJS MRP2 cMRP |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | myricetin results in decreased activity of ABCC2 protein |
decreases activity
|
protein |
15670588
|
C040015 | 397 |
ARHGDIB
D4 GDIA2 GDID4 LYGDI Ly-GDI RAP1GN1 RhoGDI2 |
Rho GDP dissociation inhibitor (GDI) beta | myricetin results in increased cleavage of ARHGDIB protein |
increases cleavage
|
protein |
15748703
|
C040015 | 581 |
BAX
BCL2L4 |
BCL2-associated X protein | myricetin results in decreased expression of BAX protein |
decreases expression
|
protein |
15748703
|
C040015 | 581 |
BAX
BCL2L4 |
BCL2-associated X protein | Tetradecanoylphorbol Acetate inhibits the reaction [myricetin results in decreased expression of BAX protein] |
decreases expression
/ decreases reaction |
protein |
15748703
|
C040015 | 596 |
BCL2
Bcl-2 PPP1R50 |
B-cell CLL/lymphoma 2 | myricetin results in decreased expression of BCL2 protein |
decreases expression
|
protein |
15748703
|
C040015 | 596 |
BCL2
Bcl-2 PPP1R50 |
B-cell CLL/lymphoma 2 | Tetradecanoylphorbol Acetate inhibits the reaction [myricetin results in decreased expression of BCL2 protein] |
decreases expression
/ decreases reaction |
protein |
15748703
|
C040015 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | myricetin results in increased activity of CASP3 protein |
increases activity
|
protein |
15748703
|
C040015 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | myricetin results in increased cleavage of CASP3 protein |
increases cleavage
|
protein |
19397994
|
C040015 | 842 |
CASP9
APAF-3 APAF3 ICE-LAP6 MCH6 PPP1R56 |
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) | myricetin results in increased activity of CASP9 protein |
increases activity
|
protein |
15748703
|
C040015 | 847 |
CAT
|
catalase (EC:1.11.1.6) | myricetin inhibits the reaction [Rotenone results in increased activity of CAT protein] |
decreases reaction
/ increases activity |
protein |
15904944
|
C040015 | 891 |
CCNB1
CCNB |
cyclin B1 | myricetin results in decreased expression of CCNB1 mRNA |
decreases expression
|
mRNA |
19397994
|
C040015 | 891 |
CCNB1
CCNB |
cyclin B1 | myricetin results in decreased expression of CCNB1 protein |
decreases expression
|
protein |
19397994
|
C040015 | 1026 |
CDKN1A
CAP20 CDKN1 CIP1 MDA-6 P21 SDI1 WAF1 p21CIP1 |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) | myricetin results in increased expression of CDKN1A mRNA |
increases expression
|
mRNA |
19397994
|
C040015 | 1026 |
CDKN1A
CAP20 CDKN1 CIP1 MDA-6 P21 SDI1 WAF1 p21CIP1 |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) | myricetin results in increased expression of CDKN1A protein |
increases expression
|
protein |
19397994
|
C040015 | 1031 |
CDKN2C
INK4C p18 p18-INK4C |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | myricetin results in increased expression of CDKN2C mRNA |
increases expression
|
mRNA |
18331776
|
C040015 | 1312 |
COMT
|
catechol-O-methyltransferase (EC:2.1.1.6) | [myricetin co-treated with COMT protein] results in decreased activity of DNMT1 protein |
affects cotreatment
/ decreases activity |
protein |
16037419
|
C040015 | 1499 |
CTNNB1
CTNNB MRD19 armadillo |
catenin (cadherin-associated protein), beta 1, 88kDa | myricetin results in decreased expression of CTNNB1 protein |
decreases expression
|
protein |
22245592
|
C040015 | 1499 |
CTNNB1
CTNNB MRD19 armadillo |
catenin (cadherin-associated protein), beta 1, 88kDa | [myricetin results in increased activity of SIRT1 protein] which results in decreased expression of CTNNB1 protein |
decreases expression
/ increases activity |
protein |
22245592
|
C040015 | 54205 |
CYCS
CYC HCS THC4 |
cytochrome c, somatic | myricetin affects the localization of CYCS protein |
affects localization
|
protein |
15748703
|
C040015 | 54205 |
CYCS
CYC HCS THC4 |
cytochrome c, somatic | Tetradecanoylphorbol Acetate inhibits the reaction [myricetin affects the localization of CYCS protein] |
affects localization
/ decreases reaction |
protein |
15748703
|
C040015 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | myricetin results in decreased activity of CYP1A1 protein |
decreases activity
|
protein |
16271822
21482471 |
C040015 | 1545 |
CYP1B1
CP1B CYPIB1 GLC3A P4501B1 |
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) | myricetin results in decreased activity of CYP1B1 protein |
decreases activity
|
protein |
16271822
21482471 |
C040015 | 1786 |
DNMT1
ADCADN AIM CXXC9 DNMT HSN1E MCMT |
DNA (cytosine-5-)-methyltransferase 1 (EC:2.1.1.37) | [myricetin co-treated with COMT protein] results in decreased activity of DNMT1 protein |
affects cotreatment
/ decreases activity |
protein |
16037419
|
C040015 | 1786 |
DNMT1
ADCADN AIM CXXC9 DNMT HSN1E MCMT |
DNA (cytosine-5-)-methyltransferase 1 (EC:2.1.1.37) | myricetin results in decreased activity of DNMT1 protein |
decreases activity
|
protein |
16037419
|
C040015 | 54583 |
EGLN1
C1orf12 ECYT3 HIF-PH2 HIFPH2 HPH-2 HPH2 PHD2 SM20 ZMYND6 |
egl-9 family hypoxia-inducible factor 1 (EC:1.14.11.29) | myricetin results in decreased expression of EGLN1 protein |
decreases expression
|
protein |
22245592
|
C040015 | 54583 |
EGLN1
C1orf12 ECYT3 HIF-PH2 HIFPH2 HPH-2 HPH2 PHD2 SM20 ZMYND6 |
egl-9 family hypoxia-inducible factor 1 (EC:1.14.11.29) | [myricetin results in increased activity of SIRT1 protein] which results in decreased expression of EGLN1 protein |
decreases expression
/ increases activity |
protein |
22245592
|
C040015 | 2203 |
FBP1
FBP |
fructose-1,6-bisphosphatase 1 (EC:3.1.3.11) | myricetin results in decreased expression of FBP1 mRNA |
decreases expression
|
mRNA |
18331776
|
C040015 | 3082 |
HGF
DFNB39 F-TCF HGFB HPTA SF |
hepatocyte growth factor (hepapoietin A; scatter factor) | myricetin inhibits the reaction [HGF protein results in increased phosphorylation of MET protein] |
decreases reaction
/ increases phosphorylation |
protein |
19244381
|
C040015 | 3091 |
HIF1A
HIF-1A HIF-1alpha HIF1 HIF1-ALPHA MOP1 PASD8 bHLHe78 |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | [myricetin results in increased activity of SIRT1 protein] which results in increased expression of HIF1A protein |
increases activity
/ increases expression |
protein |
22245592
|
C040015 | 3091 |
HIF1A
HIF-1A HIF-1alpha HIF1 HIF1-ALPHA MOP1 PASD8 bHLHe78 |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | myricetin results in increased expression of HIF1A protein |
increases expression
|
protein |
22245592
|
C040015 | 3162 |
HMOX1
HMOX1D HO-1 HSP32 bK286B10 |
heme oxygenase (decycling) 1 (EC:1.14.99.3) | myricetin results in increased expression of HMOX1 protein |
increases expression
|
protein |
16799064
|
C040015 | 3569 |
IL6
BSF2 HGF HSF IFNB2 IL-6 |
interleukin 6 (interferon, beta 2) | myricetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein] |
affects cotreatment
/ decreases reaction / increases secretion |
protein |
18958421
|
C040015 | 4233 |
MET
AUTS9 HGFR RCCP2 c-Met |
met proto-oncogene (EC:2.7.10.1) | myricetin inhibits the reaction [HGF protein results in increased phosphorylation of MET protein] |
decreases reaction
/ increases phosphorylation |
protein |
19244381
|
C040015 | 4318 |
MMP9
CLG4B GELB MANDP2 MMP-9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) | myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] |
decreases reaction
/ increases activity |
protein |
19804834
|
C040015 | 4609 |
MYC
MRTL MYCC bHLHe39 c-Myc |
v-myc avian myelocytomatosis viral oncogene homolog | myricetin results in decreased expression of MYC protein |
decreases expression
|
protein |
22245592
|
C040015 | 4609 |
MYC
MRTL MYCC bHLHe39 c-Myc |
v-myc avian myelocytomatosis viral oncogene homolog | [myricetin results in increased activity of SIRT1 protein] which results in decreased expression of MYC protein |
decreases expression
/ increases activity |
protein |
22245592
|
C040015 | 4780 |
NFE2L2
NRF2 |
nuclear factor, erythroid 2-like 2 | myricetin results in increased expression of NFE2L2 protein |
increases expression
|
protein |
16799064
|
C040015 | 8505 |
PARG
PARG99 |
poly (ADP-ribose) glycohydrolase (EC:3.2.1.143) | myricetin results in decreased activity of PARG protein |
decreases activity
|
protein |
19840838
|
C040015 | 142 |
PARP1
ADPRT ADPRT_1 ADPRT1 ARTD1 PARP PARP-1 PPOL pADPRT-1 |
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) | myricetin results in decreased activity of PARP1 protein |
decreases activity
|
protein |
17884996
|
C040015 | 142 |
PARP1
ADPRT ADPRT_1 ADPRT1 ARTD1 PARP PARP-1 PPOL pADPRT-1 |
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) | myricetin results in increased cleavage of PARP1 protein |
increases cleavage
|
protein |
15748703
|
C040015 | 8000 |
PSCA
PRO232 |
prostate stem cell antigen | myricetin results in decreased expression of PSCA mRNA |
decreases expression
|
mRNA |
18331776
|
C040015 | 5743 |
PTGS2
COX-2 COX2 GRIPGHS PGG/HS PGHS-2 PHS-2 hCox-2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] |
decreases reaction
/ increases expression |
protein |
19804834
|
C040015 | 5970 |
RELA
NFKB3 p65 |
v-rel avian reticuloendotheliosis viral oncogene homolog A | myricetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of and results in increased activity of RELA protein] |
affects cotreatment
/ affects localization / decreases reaction / increases activity |
protein |
18958421
|
C040015 | 23411 |
SIRT1
SIR2L1 |
sirtuin 1 | myricetin results in increased activity of SIRT1 protein |
increases activity
|
protein |
22245592
|
C040015 | 23411 |
SIRT1
SIR2L1 |
sirtuin 1 | [myricetin results in increased activity of SIRT1 protein] which results in decreased expression of CTNNB1 protein |
decreases expression
/ increases activity |
protein |
22245592
|
C040015 | 23411 |
SIRT1
SIR2L1 |
sirtuin 1 | [myricetin results in increased activity of SIRT1 protein] which results in decreased expression of EGLN1 protein |
decreases expression
/ increases activity |
protein |
22245592
|
C040015 | 23411 |
SIRT1
SIR2L1 |
sirtuin 1 | [myricetin results in increased activity of SIRT1 protein] which results in decreased expression of MYC protein |
decreases expression
/ increases activity |
protein |
22245592
|
C040015 | 23411 |
SIRT1
SIR2L1 |
sirtuin 1 | [myricetin results in increased activity of SIRT1 protein] which results in increased expression of HIF1A protein |
increases activity
/ increases expression |
protein |
22245592
|
C040015 | 23411 |
SIRT1
SIR2L1 |
sirtuin 1 | myricetin results in increased expression of SIRT1 protein |
increases expression
|
protein |
22245592
|
C040015 | 6513 |
SLC2A1
DYT17 DYT18 DYT9 EIG12 GLUT GLUT1 GLUT1DS HTLVR PED |
solute carrier family 2 (facilitated glucose transporter), member 1 | myricetin inhibits the reaction [SLC2A1 protein affects the transport of Glucose] |
affects transport
/ decreases reaction |
protein |
14642735
|
C040015 | 6513 |
SLC2A1
DYT17 DYT18 DYT9 EIG12 GLUT GLUT1 GLUT1DS HTLVR PED |
solute carrier family 2 (facilitated glucose transporter), member 1 | myricetin results in decreased activity of SLC2A1 protein |
decreases activity
|
protein |
14642735
|
C040015 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | myricetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein] |
affects cotreatment
/ decreases reaction / increases secretion |
protein |
18958421
|
C040015 | 7153 |
TOP2A
TOP2 TP2A |
topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3) | myricetin results in decreased activity of TOP2A protein |
decreases activity
|
protein |
16536579
|
C040015 | 9540 |
TP53I3
PIG3 |
tumor protein p53 inducible protein 3 | myricetin results in increased expression of TP53I3 mRNA |
increases expression
|
mRNA |
19397994
|
C040015 | 9540 |
TP53I3
PIG3 |
tumor protein p53 inducible protein 3 | myricetin results in increased expression of TP53I3 protein |
increases expression
|
protein |
19397994
|
C040015 | 8626 |
TP63
AIS B(p51A) B(p51B) EEC3 KET LMS NBP OFC8 RHS SHFM4 TP53CP TP53L TP73L p40 p51 p53CP p63 p73H p73L |
tumor protein p63 | myricetin results in increased expression of TP63 protein |
increases expression
|
protein |
19397994
|
C040015 | 7161 |
TP73
P73 |
tumor protein p73 | myricetin results in increased expression of TP73 protein |
increases expression
|
protein |
19397994
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#613780 | Aortic aneurysm, familial thoracic 7; aat7 |
Q15746
|
#613546 | Aromatase deficiency |
P11511
|
#139300 | Aromatase excess syndrome; aexs |
P11511
|
#210900 | Bloom syndrome; blm |
P54132
|
#114480 | Breast cancer |
P42336
|
#607271 | Caspase 8 deficiency |
Q14790
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#613641 | Charcot-marie-tooth disease, recessive intermediate b; cmtrib |
Q15046
|
#114500 | Colorectal cancer; crc |
P18054
P42336 Q14191 |
#612918 | Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi |
P42336
|
#615108 | Cowden syndrome 5; cws5 |
P42336
|
#613916 | Deafness, autosomal recessive 89; dfnb89 |
Q15046
|
#610549 | Diabetes mellitus, insulin-resistant, with acanthosis nigricans |
P06213
|
#125853 | Diabetes mellitus, noninsulin-dependent; niddm |
P06213
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#246200 | Donohue syndrome |
P06213
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#237500 | Dubin-johnson syndrome; djs |
Q92887
|
#133239 | Esophageal cancer |
P18054
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
#231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
#137760 | Glaucoma, primary open angle; poag |
Q16678
|
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#114550 | Hepatocellular carcinoma |
P42336
|
#609968 | Hyperinsulinemic hypoglycemia, familial, 5; hhf5 |
P06213
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#146300 | Hypophosphatasia, adult |
P05186
|
#241510 | Hypophosphatasia, childhood |
P05186
|
#241500 | Hypophosphatasia, infantile |
P05186
|
#182000 | Keratosis, seborrheic |
P42336
|
#601626 | Leukemia, acute myeloid; aml |
P36888
|
#211980 | Lung cancer |
Q14790
|
#602501 | Megalencephaly-capillary malformation-polymicrogyria syndrome; mcap |
P42336
|
#603387 | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome; mpph |
P42336
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#167000 | Ovarian cancer |
P42336
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#604229 | Peters anomaly |
Q16678
|
#172700 | Pick disease of brain |
P10636
|
#262190 | Pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities |
P06213
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#277700 | Werner syndrome; wrn |
Q14191
|
#278300 | Xanthinuria, type i |
P47989
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | disease name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00213 | Hypophosphatasia |
P05186
(related)
|
H00719 | Leprechaunism |
P06213
(related)
|
H00942 | Rabson-Mendenhall syndrome |
P06213
(related)
|
H01228 | Insulin-resistant diabetes mellitus with acanthosis nigricans (IRAN) |
P06213
(related)
|
H01267 | Familial hyperinsulinemic hypoglycemia (HHF) |
P06213
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00023 | Testicular cancer |
P10696
(marker)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P11511
(related)
|
H00794 | Aromatase excess syndrome |
P11511
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P28907
(marker)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00017 | Esophageal cancer |
P35354
(related)
|
H00025 | Penile cancer |
P35354
(related)
|
H00046 | Cholangiocarcinoma |
P35354
(related)
|
H00003 | Acute myeloid leukemia (AML) |
P36888
(related)
Q01196 (related) Q01196 (marker) Q13951 (marker) |
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00027 | Ovarian cancer |
P42336
(related)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
Q14191 (related) |
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
Q01453
(related)
Q15046 (related) |
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00108 | Autoimmune lymphoproliferative syndromes (ALPS) |
Q14790
(related)
|
H00801 | Familial thoracic aortic aneurysm and dissection (TAAD) |
Q15746
(related)
|
H00612 | Primary open angle glaucoma |
Q16678
(related)
|
H01075 | Peters anomaly |
Q16678
(related)
|
H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
H00208 | Hyperbilirubinemia |
Q92887
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|